Latest news

Filter by category:

FILTER: ALL CATEGORIESFilter by:

Latest news

28 Jul 2022

CEPI, UK MHRA, and UK Health Security Agency to advance key tools for Monkeypox vaccine research
Up to US$375k will be made available by CEPI for the development of a Monkeypox antibody standard and assays.

Read more

Read article

26 Jul 2022

CEPI statement: CEO welcomes White House Summit on the Future of COVID-19 Vaccines
Dr Richard Hatchett calls for heightened investment to develop the next generation of globally accessible COVID-19 vaccines

Read more

19 Jul 2022

Q+A: How CEPI-funded research is supporting the COVID-19 vaccine rollout
CEPI’s Director of Clinical Development, Jakob Cramer, discusses the research CEPI is supporting to inform global COVID-19 vaccination strategies.

Read more

19 Jul 2022

Aurum Institute, CEPI and Human Vaccines Project Collaborate to Research COVID-19 Vaccine Strategies for People Living With or Without HIV
CEPI-funded study in South Africa will gather important data to inform vaccination strategies in regions with high prevalence of HIV.

Read more

05 Jul 2022

Future-proofing the world against COVID-19 and other coronaviruses
Dr Melanie Saville, CEPI's top vaccine scientist, explores how the world can chart a long-term route out of the COVID-19 pandemic and beyond.

Read more

05 Jul 2022

CEPI funds consortium led by CPI to advance Caltech’s new all-in-one coronavirus vaccine
Up to $30m funding will be provided to advance the technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.

Read more

05 Jul 2022

CEPI partners with Codiak BioSciences to develop broadly protective Betacoronavirus vaccine
CEPI to provide up to US$2.5 million in seed funding to assess vaccine candidates from Codiak's pan Betacoronavirus program through preclinical studies.

Read more

13 Jun 2022

June webinars on CEPI’s open scientific calls
CEPI recently held two webinars on 28 and 29 June to provide potential applicants with an overview of our open calls and the key steps to follow during the application process.

Read more

Read article

08 Jun 2022

CEPI and Oxford Vaccine Group in UK and Brazil partner to evaluate fractional COVID-19 booster vaccines
Clinical trial in Brazil is investigating the impact of administering reduced COVID-19 booster shots instead of full doses

Read more

27 May 2022

Why the COVID-19 R&D job is not finished
The path out of the pandemic needs continued and concerted commitment to vaccine R&D

Read more

24 May 2022

Could monkeypox give us an R&D blueprint to end pandemics?
Availability of smallpox countermeasures, developed to counter bioterrorism, also give the world the means to combat monkeypox and other orthopoxviruses. What if this approach could be applied to all viral families?

Read more

©2022 CEPI. All rights reserved